Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 410

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 410
---
DED SEPTEMBER 30, 2023

| ​                                                             
 ​                                                             | ​ 
 ​ | ​ 
 ​ | Class A Common Stock 
 Shares               |   |           |   | ​ | ​ | Amount |   |     |   | ​ 
 ​ | ​ 
 ​ | Class B Common Stock 
 Shares               |   |            |   | ​ | ​ | Amount |   |      |   | ​ 
 ​ | ​ | AdditionalPaid-in Capital |   |         |   | ​ | ​ | AccumulatedDeficit |   |             |   | ​ | ​ | Total Stockholders’Deficit |   |             |   | ​ |
|:--------------------------------------------------------------|:--|:--|:---------------------|:--|----------:|:--|:--|:--|:-------|:--|----:|:--|:--|:--|:---------------------|:--|-----------:|:--|:--|:--|:-------|:--|-----:|:--|:--|:--|:--------------------------|:--|--------:|:--|:--|:--|:-------------------|:--|------------:|:--|:--|:--|:---------------------------|:--|------------:|:--|:--|
| Balance as of January 1, 2023                                 | ​ | ​ | ​                    | ​ |         — | ​ | ​ | ​ | ​      | $ |   — | ​ | ​ | ​ | ​                    | ​ |  6,900,000 | ​ | ​ | ​ | ​      | $ |  690 | ​ | ​ | ​ | ​                         | $ | 140,000 | ​ | ​ | ​ | ​                  | $ | -13,974,105 | ​ | ​ | ​ | ​                          | $ | -13,833,415 | ​ | ​ |
| Remeasurement of Class A common stock to redemption amount    | ​ | ​ | ​                    | ​ |         — | ​ | ​ | ​ | ​      | ​ |   — | ​ | ​ | ​ | ​                    | ​ |          — | ​ | ​ | ​ | ​      | ​ |    — | ​ | ​ | ​ | ​                         | ​ |       — | ​ | ​ | ​ | ​                  | ​ |     298,845 | ​ | ​ | ​ | ​